Sussex Premier Health, Hastings: Important update for patients with upcoming appointments

Tel01424 757400
Make an enquiry

Professor Umesh Dashora

Consultant Endocrinologist and Diabetologist

MBBS, MD, MRCP, FRCP (Edin), CCT (Diabetes/ Endocrinology/ General Internal Medicine), MA, MD

General Medical Council Number: 5198041

I have been a Specialist Physician from 1985, a specialist Endocrinologist and Diabetologist from 1993 and a consultant Endocrinologist and Diabetologist in the UK from 2006.

I have diverse and extensive experience of working in India, Oman and now in the UK.

 

Clinic Times

TBC

Treatment information

Some of the principal treatments carried out by Dr Umesh Dashora include:

Endocrinology and diabetes

Additional information

Qualifications:

CCT (Endocrinology, Diabetes and General Medicine) / Royal College of Physicians of the UK / 2006
Certificate of Completion of Training
CCT is a degree which is given after 5 years of training in Endocrinology and Diabetes

Professional memberships:

CPD approver, Federation of the Royal Colleges of Physicians of the UK
Fellow, Royal College of Physicians of Edinburgh
Member of the Association of British Clinical Diabetologist
Executive member of the Join British Diabetes Societies for Inpatients
Member of Diabetes UK.

  • Sinclair AJ, Bellary S, Middleton A, Morris A, Walker R, Winkley Bryant K, Dashora U, Karamat M, Rayner J, Tomlinson S, Maltese G. Type 1 Diabetes in care homes: A practical guide on management. Diabetic Medicine. 2024:e15457.
  • Abouibrahim M, Rahman M, Zafar M, Berliti S, Hacikurt K, Dashora U, Sathiskumar P. Unusual Presentation of Case of a Lung Carcinoid Tumor With Ectopic Adrenocorticotropic Secretion (EAS) Associated With Acute Weight Gain and Peripheral Edema. Cureus. 2024 Jul;16(7).
  • Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK, Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the joint British diabetes societies (JBDS) for inpatient care group. Diabetic Medicine. 2023 Mar;40(3):e15005.
  • Dashora U, Flanagan D, Rayman G, Mustafa OG, Walden E, Dhatariya K, Joint British Diabetes Societies. Optimal staffing for a good quality inpatient diabetes service. Diabetic Medicine. 2023 Oct;40(10):e15151.
  • Sinclair AJ, Bellary S, Dashora U, Abdelhafiz AH, Rowles S, Reedman L, Turner B, Green M, Forbes A, Middleton A, NAPCHD. Enhancing diabetes care for the most vulnerable in the 21st century: Interim findings of the National Advisory Panel on Care Home Diabetes (NAPCHD). Diabetic medicine. 2023 Aug;40(8):e15088.
  • Sinclair AJ, Bellary S, Middleton A, Morris A, Walker R, Winkley Bryant K, Dashora U, Karamat M, Rayner J, Tomlinson S, Maltese G. Type 1 Diabetes in care homes: A practical guide on management. Diabetic Medicine. 2024:e15457.
  • Chua A, Drake W, Yoeli H, Oyibo P, Dashora U, Till D, Cartwright M, Llahana S. Exploring experiences of patients with adrenal insufficiency (AI) using parenteral hydrocortisone injection device to manage adrenal crisis: a qualitative interview study. InEndocrine Abstracts 2024 May 6 (Vol. 99). Bioscientifica.
  • Evans M, Morgan AR, Bain SC, Davies S, Hicks D, Brown P, Yousef Z, Dashora U, Viljoen A, Beba H, Strain WD. Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice. Diabetes Therapy. 2022 Jan 19:1
  • Khunti K, Ruan Y, Davies J, Field BC, Harris S, Kosiborod M, Nagi D, Narendran P, Patel D, Ryder RE, Várnai KA. Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19. Diabetes Care. 2022 Sep 8.
  • Dashora U. Notes from the Diabetes UK conference. British Journal of Diabetes. 2022 Jun 29;22(1):52-3.
  • Evans M, Morgan AR, Bain SC, Davies S, Dashora U, Sinha S, Seidu S, Patel DC, Beba H, Strain WD. Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently. Diabetes Therapy. 2022 Mar 29:1-23.
  • Dashora U, Levy N, Dhatariya K, Willer N, Castro E, Murphy HR. Reply to Rowe et al Re: Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes-an updated guideline from the Joint British Diabetes Society for Inpatient Care Dashora et al. Diabetic Medicine. 2022; 39: e14744. Diabetic medicine: a journal of the British Diabetic Association. 2022 Apr 14:e14844.
  • Dashora U, Levy N, Dhatariya K, Willer N, Castro E, Murphy HR, Joint British Diabetes Societies In Patient group. Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes–an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabetic Medicine. 2022 Feb;39(2):e14744.
  • Evans M, Lewis RD, Morgan AR, Whyte MB, Hanif W, Bain SC, Davies S, Dashora U, Yousef Z, Patel DC, Strain WD. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives. Advances in therapy. 2021 Nov 5:1-1.
  • Ruan Y, Ryder RE, De P, Field BC, Narendran P, Iqbal A, Dashora U et al. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. Diabetologia. 2021 Aug;64(8):1717-24.
  • Dashora U, Patel DC, Gregory R, Winocour P, Dhatariya K, Rowles S, Macklin A, Rayman G, Nagi D, ABCD executive committee, supported by Diabetes UK. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020). Diabetic Medicine. 2021 Feb;38(2):e14458.
  • Evans, M., Morgan, A. R., Patel, D., Dhatariya, K., Greenwood, S., Newland-Jones, P., … & Dashora, U. (2021). Risk prediction of the diabetes missing million: identifying individuals at high risk of diabetes and related complications. Diabetes Therapy, 12(1), 87-105.
  • Zafar, M., Karkhanis, M., Shahbaz, M., Khanna, A., Barry, L., Alam, S., … & Dashora, U. (2021). Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study. Postgraduate Medical Journal.
  • Zafar, M., Shahbaz, M., Karkhanis, M., Abdelbagi, M., Makanjuola, O. A., Pun, B., … & Dashora, U. (2021). A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?. Cureus, 13(7).
  • Evans M, Morgan AR, Whyte MB, Hanif W, Bain SC, Kalra PA, Davies S, Dashora U, Yousef Z, Patel DC, Strain WD. New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice. Drugs. 2021 Dec 21:1-2.
  • Dashora U, Ahmed S, Bossman I, Aung KK, Castro E, Sathiskumar P. A service evaluation of the impact of adoption of JBDS guidelines for the management of glucose during labour and birth in women with diabetes. British Journal of Diabetes. 2021 May 28;21(1):67-75.
  • Dashora U, Ahmed S, Shaiq S, Castro E, Khan SA, Bossman I, Sathiskumar P. A case series of Humulin RU‐500 in insulin resistant people with type 2 diabetes. Practical Diabetes. 2021 Nov;38(6):16-22.
  • Zafar M, Randhawa RS, Peacock-Young B, Eldebri R, Dashora U. Blurring of vision with malaise. The journal of the Royal College of Physicians of Edinburgh. 2021 Mar 1;51(1):49-52.
  • Nagi DK, Rowles S, Macklin A, Dashora U, Oliver H, Patel D. Integrated diabetes care: The Association of British Clinical Diabetologists (ABCD) national survey report. British Journal of Diabetes. 2021 Dec 17;21(2):272-80.
  • Dashora U, Laurent DB, Leech N, Dhatariya K, Sampson M, Castro E, Hillson R, Jones C. The Rowan Hillson Inpatient Safety Award 2019 for the best perioperative pathway for people with diabetes. British Journal of Diabetes. 2021 May 28;21(1):149-53.
  • Dashora U, Gregory R, Winocour P, Dhatariya K, Rowles S, Macklin A, Rayman G, Nagi D, Whitehead K, Beba H, De P. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021). Clinical Medicine. 2021 May;21(3):204.
  • Nagi DK, Dashora U. ABCD debate at the annual ABCD virtual meeting 18 December 2020. British Journal of Diabetes. 2021 Dec 17;21(2):286-8.

I am the Deputy Chief of Medicine at Conquest Hospital.
CPD approver for the Royal College of Physicians of London.
I am undergraduate lead for Brighton and Sussex Medical School at East Sussex.
I am currently leading on OP digital electronic patient record.

In these roles I have had the opportunity to lead on many national guidelines and workstreams to standardise care of people with diabetes and endocrine problems.

 

 

I have enjoyed an extensive and diverse experience of growing up, training and learning in India, Oman and in the various parts of UK including Newcastle, Sunderland, Southampton and now Hastings.

I regularly play badminton and swim to keep fit. I also enjoy public speaking.

I am very lucky to have an understanding wife and bright children who have quickly grown up.

Private secretary: Mrs Balabavani Dashora

Private secretary telephone: 07817371053

Private secretary email: b.dashora@yahoo.co.uk

How can we help you?

Meet our consultants

Treatments and services

Enquire online

Interested in finding out more?

Speak to a member of our team

Phone01424 757400




Date of Birth:



Nature of Request:
Funding Option:


Email:
SMS:

Enquiry form

DD slash MM slash YYYY

Marketing Information
Sussex Premier Health would like to provide you with marketing information about products and services offered by Sussex Premier Health and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.
Please tick the box(es) to confirm your consent to receive marketing information from Sussex Premier Health:

Section Break

Marketing

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Section Break

Consent(Required)